“A major new study claims women who take the most commonly used form of hormone replacement therapy (HRT) are nearly three times more likely to develop breast cancer than those who do not.
“The Institute of Cancer Research looked at six years of data for 39,000 menopausal women, of whom 775 had developed the illness. It found those taking combined oestrogen-progestogen HRT – the most popular form – were 2.74 times more likely to develop breast cancer than those not using any HRT at all.
“The risk declined when women stopped taking the treatment, while there was no danger at all connected with taking only oestrogen, which accounts for half of all prescriptions.”
Do you have questions about this story? Let us know in a comment below. If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to use our Ask Cancer Commons service.
“Acupuncture may be a viable treatment for women experiencing hot flashes as a result of estrogen-targeting therapies to treat breast cancer, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. Hot flashes are particularly severe and frequent in breast cancer survivors, but current FDA-approved remedies for these unpleasant episodes, such as hormone replacement therapies are off-limits to breast cancer survivors because they include estrogen. The results of the study are published this week in the Journal of Clinical Oncology.
” ‘Though most people associate hot flashes with menopause, the episodes also affect many breast cancer survivors who have low estrogen levels and often undergo premature menopause, following treatment with chemotherapy or surgery,’ said lead author Jun J. Mao, MD, MSCE, associate professor of Family Medicine and Community Health. ‘These latest results clearly show promise for managing hot flashes experienced by breast cancer survivors through the use of acupuncture, which in previous studies has also been proven to be an effective treatment for joint pain in this patient population.’ “